New Jersey Medical School, PAREXEL Collaborate to Optimize Clinical Trial Services
Wednesday, July 3, 2013 - 13:30
in Health & Medicine
Rutgers New Jersey Medical School (NJMS) has been selected by PAREXEL International Corporation, a leading global biopharmaceutical services provider, as a Key Alliance Site. This status will give NJMS ongoing long-term access to clinical trial opportunities through PAREXEL's broad client base in the pharmaceutical industry.